Rossari Biotech

{
  "main_header": {
    "sid": 1003405,
    "name": "Rossari Biotech",
    "stock_name": "Rossari Biotech",
    "full_name": "Rossari Biotech Ltd",
    "name_url": "stocks-analysis/rossari-biotech",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "512.75",
    "chg": -13.75,
    "chgp": "-2.61%",
    "dir": -1,
    "prev_price": "526.50",
    "mcapval": "2,895.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 543213,
    "symbol": "ROSSARI",
    "ind_name": "Specialty Chemicals",
    "ind_code": 11,
    "sector_id": 74,
    "indexname": "India SENSEX",
    "isin": "INE02A801020",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "23:29 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "37.46 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/rossari-biotech-1003405-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Rossari Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rossari-biotech-ltd-is-rated-sell-4142750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/RossariBiotechL_mojoScore_4142750.png",
        "date": "2026-08-08 10:10:40",
        "description": "Rossari Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Rossari Biotech Gains 3.28%: Mixed Technical Signals Shape Weekly Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-gains-328-mixed-technical-signals-shape-weekly-momentum-4131435",
        "imagepath": "",
        "date": "2026-08-01 12:05:34",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jul:</strong> Intraday high of Rs.523 with a 7.14% surge, breaking a six-day decline</p>\n                    <p><strong>27 Jul:</strong> Mojo Grade downgraded to Sell amid bearish momentum</p>\n                    <p><strong>28 Jul:</strong> Mixed technical signals emerge despite a 6.59% price gain</p>\n                    <p><strong>31 Jul:</strong> Week closes at Rs.505.35, up 3.28% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\">\n                        <div class=\"stat-label\">Week Open</div>\n                        <div class=\"stat-value\">Rs.489.30</div>\n                    </div>\n                    ..."
      },
      {
        "title": "Rossari Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rossari-biotech-ltd-is-rated-sell-4123998",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RossariBiotechL_mojoScore_4123998.png",
        "date": "2026-07-28 10:11:53",
        "description": "Rossari Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Rossari Biotech Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-4123453",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RossariBiotechL_technicaldot_4123453.png",
        "date": "2026-07-28 08:05:47",
        "description": "Rossari Biotech Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in price momentum and technical indicators, reflecting a complex market sentiment. Despite a robust day change of 6.59%, the company’s overall technical outlook remains cautiously bearish, with mixed signals from key momentum and trend indicators."
      },
      {
        "title": "Rossari Biotech Ltd Surges 7.14% to Day's High of Rs 523 — Outperforms Sector by 5.21 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-ltd-hits-intraday-high-with-714-surge-on-27-jul-2026-4122881",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RossariBiotechL_priceRelatedfactors_4122881.png",
        "date": "2026-07-27 15:32:57",
        "description": "The Sensex advanced 1.06% on 27 Jul 2026, yet Rossari Biotech Ltd outpaced the broader market with a 7.14% gain, reaching an intraday high of Rs 523. This 5.21 percentage-point outperformance over its Specialty Chemicals sector peers highlights a distinctly stock-specific rally rather than a market-wide lift."
      },
      {
        "title": "Rossari Biotech Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/rossari-biotech-ltd-faces-bearish-momentum-amid-technical-downgrade-4121899",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RossariBiotechL_technicaldot_4121899.png",
        "date": "2026-07-27 08:03:07",
        "description": "Rossari Biotech Ltd, a small-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined to ₹489.30, down 0.37% from the previous close of ₹491.10, reflecting growing investor caution amid weakening technical signals and underperformance relative to benchmark indices."
      },
      {
        "title": "Are Rossari Biotech Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-rossari-biotech-ltd-latest-results-good-or-bad-4108271",
        "imagepath": "",
        "date": "2026-07-19 19:12:17",
        "description": "Rossari Biotech Ltd's latest financial results for Q1 FY27 reveal a complex picture characterized by strong revenue growth alongside notable challenges in profitability and operational efficiency. The company reported net sales of ₹697.20 crores, marking a year-on-year increase of 28.23% and a sequential growth of 1.80%. This performance represents the highest quarterly sales in the company's history, indicating robust market demand.\n\nHowever, the net profit for the same quarter was ₹35.10 crores, which reflects a decline of 23.65% compared to the previous quarter, despite a year-on-year increase of 4.46%. This divergence between revenue growth and profit performance raises concerns about the company's operational efficiency and cost management, particularly in light of rising interest costs and increased depreciation charges.\n\nThe operating margin improved slightly to 11.56%, up 28 basis points from the pr..."
      },
      {
        "title": "Rossari Biotech Q1 FY27: Margin Pressures Dampen Growth Story Despite Revenue Surge",
        "link": "https://www.marketsmojo.com/news/result-analysis/rossari-biotech-q1-fy27-margin-pressures-dampen-growth-story-despite-revenue-surge-4107757",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RossariBiotech_quaterlyResult_4107757.png",
        "date": "2026-07-18 21:46:00",
        "description": "Rossari Biotech Ltd., a specialty chemicals manufacturer, reported a consolidated net profit of ₹35.10 crores for Q1 FY27, representing a sharp 23.65% sequential decline from ₹45.97 crores in Q4 FY26, though posting a modest 4.46% year-on-year growth from ₹33.60 crores in Q1 FY26. The ₹2,908 crore market capitalisation company's stock has responded negatively to the mixed results, declining 2.13% to ₹530.70 following the announcement, reflecting investor concerns over deteriorating profitability metrics despite robust topline expansion."
      },
      {
        "title": "Rossari Biotech Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/rossari-biotech-ltd-is-rated-sell-4106144",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/RossariBiotechL_mojoScore_4106144.png",
        "date": "2026-07-17 10:11:00",
        "description": "Rossari Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 255,
    "sid": "1003405",
    "stock_news_url": "https://www.marketsmojo.com/news/rossari-biotech-1003405"
  },
  "announcements": [
    {
      "caption": "Update On Investor Call.",
      "datetime": "06-Aug-2026",
      "details": "",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "03-Aug-2026",
      "details": "Intimation of Analyst/ Institutional Investor Meet/ Con. Call/Updates.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "24-Jul-2026",
      "details": "Intimation of Transcript of Q1 FY 27 for the Earnings Conference Call held on July 20 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Rossari Biotech Ltd has declared <strong>25%</strong> dividend, ex-date: 10 Jul 26",
          "dt": "2026-07-10",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Rossari Biotech Ltd is Rated Sell

2026-08-08 10:10:40

Rossari Biotech Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Rossari Biotech Gains 3.28%: Mixed Technical Signals Shape Weekly Momentum

2026-08-01 12:05:34

Key Events This Week

27 Jul: Intraday high of Rs.523 with a 7.14% surge, breaking a six-day decline

27 Jul: Mojo Grade downgraded to Sell amid bearish momentum

28 Jul: Mixed technical signals emerge despite a 6.59% price gain

31 Jul: Week closes at Rs.505.35, up 3.28% for the week

Week Open

Rs.489.30

...

Read full news article

Rossari Biotech Ltd is Rated Sell

2026-07-28 10:11:53

Rossari Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 28 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Rossari Biotech Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-07-28 08:05:47

Rossari Biotech Ltd, a small-cap player in the Specialty Chemicals sector, has experienced a notable shift in price momentum and technical indicators, reflecting a complex market sentiment. Despite a robust day change of 6.59%, the company’s overall technical outlook remains cautiously bearish, with mixed signals from key momentum and trend indicators.

Read full news article

Rossari Biotech Ltd Surges 7.14% to Day's High of Rs 523 — Outperforms Sector by 5.21 Percentage Points

2026-07-27 15:32:57

The Sensex advanced 1.06% on 27 Jul 2026, yet Rossari Biotech Ltd outpaced the broader market with a 7.14% gain, reaching an intraday high of Rs 523. This 5.21 percentage-point outperformance over its Specialty Chemicals sector peers highlights a distinctly stock-specific rally rather than a market-wide lift.

Read full news article

Rossari Biotech Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-07-27 08:03:07

Rossari Biotech Ltd, a small-cap player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined to ₹489.30, down 0.37% from the previous close of ₹491.10, reflecting growing investor caution amid weakening technical signals and underperformance relative to benchmark indices.

Read full news article

Are Rossari Biotech Ltd latest results good or bad?

2026-07-19 19:12:17

Rossari Biotech Ltd's latest financial results for Q1 FY27 reveal a complex picture characterized by strong revenue growth alongside notable challenges in profitability and operational efficiency. The company reported net sales of ₹697.20 crores, marking a year-on-year increase of 28.23% and a sequential growth of 1.80%. This performance represents the highest quarterly sales in the company's history, indicating robust market demand. However, the net profit for the same quarter was ₹35.10 crores, which reflects a decline of 23.65% compared to the previous quarter, despite a year-on-year increase of 4.46%. This divergence between revenue growth and profit performance raises concerns about the company's operational efficiency and cost management, particularly in light of rising interest costs and increased depreciation charges. The operating margin improved slightly to 11.56%, up 28 basis points from the pr...

Read full news article

Rossari Biotech Q1 FY27: Margin Pressures Dampen Growth Story Despite Revenue Surge

2026-07-18 21:46:00

Rossari Biotech Ltd., a specialty chemicals manufacturer, reported a consolidated net profit of ₹35.10 crores for Q1 FY27, representing a sharp 23.65% sequential decline from ₹45.97 crores in Q4 FY26, though posting a modest 4.46% year-on-year growth from ₹33.60 crores in Q1 FY26. The ₹2,908 crore market capitalisation company's stock has responded negatively to the mixed results, declining 2.13% to ₹530.70 following the announcement, reflecting investor concerns over deteriorating profitability metrics despite robust topline expansion.

Read full news article

Rossari Biotech Ltd is Rated Sell

2026-07-17 10:11:00

Rossari Biotech Ltd is rated Sell by MarketsMOJO, with this rating last updated on 24 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News